日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to 'Engineered nano-bacteria hybrids for precision cancer immunotherapy' [Mater. Today Bio 35 (2025) 102484]

对“用于精准癌症免疫疗法的工程纳米细菌杂交体”的更正[Mater. Today Bio 35 (2025) 102484]

Yu, Liang; Qiu, Yuling; Liu, Baorui; Zhen, Xu; Li, Rutian

Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors

具有肿瘤穿透能力的抗MSLN嵌合抗原受体样NK细胞疗法(uCAR-like NK)用于实体瘤

An, Mengchao; Wang, Ying; Shao, Jie; Wu, Siwen; Yan, Jiayao; Li, Yuxiang; Zhong, Liqing; Guo, Jingyi; Chen, Tianran; Tian, Manman; Liu, Qin; Li, Rutian; Liu, Baorui

Verteporfin-Mediated In Situ Nanovaccine Based on Local Conventional-Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect

基于局部常规剂量低分割放射疗法的维替泊芬介导的原位纳米疫苗可增强抗肿瘤和免疫调节作用

Zhang, Zhifan; Li, Lin; Ge, Yuchen; Chen, Anni; Diao, Shanchao; Yang, Yueling; Chen, Qianyue; Zhou, Yingling; Shao, Jie; Meng, Fanyan; Yu, Lixia; Tian, Manman; Qian, Xiaoping; Lin, Zhaoyu; Xie, Chen; Liu, Baorui; Li, Rutian

RASON promotes KRAS(G12C)-driven tumor progression and immune evasion in non-small cell lung cancer.

RASON 促进 KRAS(G12C) 驱动的非小细胞肺癌肿瘤进展和免疫逃逸

Wu Jianzhuang, Xie Kexin, Zhang Yixuan, Zhang Weiyi, Cheng Rongjie, Zhang Yaliang, Xia Yugui, Liu Tongyan, Yin Rong, Qiu Yudong, Xu Tao, Li Rutian, Sun Qi, Yan Chao

Enzymatically responsive nanocarriers targeting PD-1 and TGF-β pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy

靶向PD-1和TGF-β通路的酶响应性纳米载体可逆转免疫治疗耐药性并产生强大的治疗效果。

Yen, Ying-Tzu; Zhang, Zhifan; Chen, Anni; Qiu, Yuling; Liu, Qin; Wang, Qin; Li, Chunhua; Wang, Chun; Qian, Xiaoping; Shao, Jie; Meng, Fanyan; Yu, Lixia; Liu, Baorui; Li, Rutian

Novel tetrameric bispecific KK-LC-1×CD16A-armed memory-like NK cells enhance antitumor efficacy in gastric cancer

新型四聚体双特异性KK-LC-1×CD16A武装的记忆样NK细胞增强胃癌的抗肿瘤疗效

Li, Mengzhu; Chen, Tianran; Wu, Siwen; Li, Yuxiang; Liu, Qin; Wang, Ying; Guo, Jingyi; Cen, Lanqi; Zou, Lu; Tian, Manman; Chen, Wenxiu; Li, Rutian; Shen, Jie; Liu, Baorui; Shao, Jie

Biomineralized engineered Lactococcus lactis-based in situ vaccination enhances antitumor immunity via sequential activation of chemo-immunotherapy

基于生物矿化工程化乳酸乳球菌的原位疫苗可通过化疗-免疫疗法的顺序激活增强抗肿瘤免疫力

Chen, Ziqi; Ke, Yaohua; Zhu, Junmeng; Cen, Lanqi; Rao, Wenmei; Hong, Sen; Wang, Yan; Shao, Jie; Chu, Yanhong; Qian, Xiaoping; Liu, Baorui; Li, Rutian; Liu, Qin

Engineered nano-bacteria hybrids for precision cancer immunotherapy

用于精准癌症免疫疗法的工程纳米细菌杂合体

Yu, Liang; Qiu, Yulin; Liu, Baorui; Zhen, Xu; Li, Rutian

De novo design of a two-step approach targeting Claudin-6 for enhanced drug delivery to solid tumors

从头设计一种针对 Claudin-6 的两步法,以增强药物向实体瘤的递送

Yan, Jiayao; Zhong, Liqing; Chen, Xiaotong; Li, Lin; Liu, Fangcen; Lei, Lei; An, Mengchao; Wei, Xiao; Wang, Ying; Chen, Tianran; Guo, Jingyi; Shao, Jie; Yu, Xiaoxiao; Zhao, Yingjie; Li, Rutian; Liu, Qin; Liu, Baorui

Expression of Cancer-Testis Antigens MAGE-A1, MAGE-A4, NY-ESO-1 and PRAME in Bone and Soft Tissue Sarcomas: The Experience From a Single Center in China

中国某中心骨和软组织肉瘤中癌睾丸抗原MAGE-A1、MAGE-A4、NY-ESO-1和PRAME的表达:来自中国的单一中心经验

Chen, Anni; Qiu, Yuling; Yen, Ying-Tzu; Wang, Chun; Wang, Xiaolu; Li, Chunhua; Wei, Zijian; Li, Lin; Yu, Lixia; Liu, Fangcen; Li, Rutian